To determine whether the presence of histologic chorioamnionitis is associated with the severity of Persistent Pulmonary Hypertension of the Newborn (PPHN) as evidenced by the use of exogenous nitric oxide (iNO), high-frequency oscillatory ventilation (HFOV), extra-corporeal membrane oxygenation (ECMO) and/or death.
INTRODUCTION
Persistent Pulmonary Hypertension of the Newborn (PPHN) is a serious clinical condition characterized by marked pulmonary hypertension with right-to-left extrapulmonary shunting across the foramen ovale and ductus arteriosus with resultant hypoxemia. Pulmonary hypertension may be idiopathic in origin or it may evolve secondary to multiple neonatal disorders including congenital pneumonia and/or sepsis, hyaline membrane disease, meconium aspiration and congenital diaphragmatic hernia. 1, 2 Although there is lack of recent epidemiologic studies at a national level, institutional reports suggest that PPHN occurs in approximately one in 1000 live term newborns and is associated with significant mortality. 1, 3, 4 The introduction of advanced interventions, that is, inhaled nitric oxide (iNO) either alone or in conjunction with high-frequency ventilation (HFV) has not changed mortality significantly, but has reduced the need for extracorporeal membrane oxygenation (ECMO). 5, 6 Nitric oxide (NO) production is considered to play a major role in modulating pulmonary vascular tone resulting in vasodilation and increased pulmonary blood flow. 7 Thus, factors influencing NO production and/or function likely play a critical role in the pathogenesis of PPHN. Recent experimental data indicate that proinflammatory mediators, that is, cytokines and c-reactive protein (CRP), downregulate the endothelial enzyme nitric oxide synthase (eNOS), ultimately leading to reduced NO production. [8] [9] [10] [11] This effect is more pronounced in the presence of hypoxia.
11
Proinflammatory mediators such as interleukin-6 (IL-6) are elevated in the amniotic fluid and cord blood of infants with clinical and/or histologic chorioamnionitis. 12, 13 This raises the possibility that these elevated inflammatory mediators may play a role in the genesis of PPHN. There are no data linking the presence of clinical and/or histologic chorioamnionitis and the severity of PPHN.
The objective of this retrospective study was to determine whether the presence of histological chorioamnionitis and/or funisitis is associated with the severity of PPHN as evidenced by (1) the more frequent use of exogenous NO, (2) requirement for more advanced respiratory support, that is, HFOV or ECMO and/or (3) death. Neonates with congenital abnormalities and specifically congenital diaphragmatic hernia were excluded. The following data were retrieved: birth weight, gestational age (as determined by the Ballard Score), 14 sex, race, maternal complications, that is, pregnancy-induced hypertension, labor complication including chorioamnionitis (based on maternal temperature Z381C and one or more of the following: fetal or maternal tachycardia, uterine tenderness or foul smelling amniotic fluid) 15 as well as histologic chorioamnionitis, 16 the presence of meconium-stained amniotic fluid, fetal heart rate abnormalities, mode of delivery, Apgar score at 1 and 5 minutes, the need for resuscitation, time for a resuscitation team (consisting of a neonatal fellow and/or a senior pediatric resident, resuscitation nurse and respiratory therapist) to arrive in the delivery room in relation to the birth of the infant, cord arterial blood gas parameters (pHr7.00 was regarded as severe fetal acidemia), 17, 18 the clinical course in the NICU including the extent of respiratory support, that is, ventilator support, the need for iNO, HFOV and ECMO, complications, that is, pneumothorax, the duration of hospitalization, disposition and placental pathology. The resuscitation team is called to high-risk deliveries such as in cases where there is a history of fetal heart abnormalities coupled with the presence of meconium-stained amniotic fluid. The diagnosis of PPHN was based on the following criteria: presence of hypoxemia defined as a preductal oxygen saturation (SaO 2 ) value <90% while receiving oxygen therapy, a pre-and postductal SaO 2 difference of Z10% and the absence of structural cardiac disease. The severity of PPHN was determined by assessing the need for iNO alone and/or in conjunction with HFOV, the need for ECMO or death from respiratory failure. The use of iNO in our institution is clinically indicated when the oxygenation index (OI) is Z15 on two occasions. The latter is determined as the product of the FiO 2 Â mean airway pressure/postductal PaO 2 . In general, HFOV is used in our institution when there is progressive respiratory failure on increasing conventional ventilator support, that is, mean airway pressure Z10 cm of water coupled with FiO 2 of 1.0±radiographic evidence of pulmonary atelectasis.
METHODS

Data
Statistical Analysis
The primary outcome was the need for iNO therapy in the presence or absence of histological chorioamnionitis and/or funisitis. Groups were evaluated using w 2 analysis and Student's t-test was used for continuous variable. Odds ratio estimates were calculated using the Woolf method. Continuous variables were expressed as mean±standard deviation.
RESULTS
There were 31,990 deliveries during the study period of which 28,834 were considered term, that is, Z37 weeks gestation. A total of 53 term neonates were diagnosed with PPHN and admitted to the NICU; this represents 1.8 cases per 1000 live births. In all, 24 neonates were excluded from the study due to a diagnosis of congenital diaphragmatic hernia (n ¼ 10) or the lack of placental pathology (n ¼ 14). Thus, 29 neonates fulfilled the inclusion criteria for the study.
Perinatal Characteristics
The perinatal characteristics of the 29 neonates are listed in Table 1 . A total of 23 (80%) neonates were delivered by cesarean section, including nine (31%) who were delivered by emergent section. The most frequent perinatal complications were meconium-stained amniotic fluid and/or fetal heart rate abnormalities, n ¼ 14 (48%). Clinical chorioamnionitis was noted in only two (7%) neonates. Resuscitative intervention in the delivery room included oxygen therapy only n ¼ 5 (17%), bag and mask and/or continuous positive airway pressure ventilation (CPAP) for respiratory distress n ¼ 4 (14%), intubation for respiratory distress and/or respiratory depression n ¼ 14 (48%) and cardiopulmonary resuscitation (CPR, which includes endotracheal intubation, chest compressions±epinephrine administration), n ¼ 6 (20%). A single pediatric provider was initially present at the delivery in 19 (66%) cases, whereas the resuscitation team was present at 10 (34%) deliveries.
Clinical Course in the NICU iNO was administered to 14 (48%) neonates, HFOV was used in seven (24%), three (10%) were placed on ECMO and two (7%) died. One of the two neonates who died developed significant intracranial hemorrhage while on ECMO and the other had a cardiopulmonary arrest immediately prior to the initiation of ECMO. Pneumothorax developed in 10 (34%) cases. The duration of ventilation was 7.0±6.6 days and duration of hospitalization was 31±28 days.
Factors Related to the Use of iNO and HFOV
Comparing neonates who required iNO and those who did not, there was no measurable difference in the proportion of infants with meconium-stained amniotic fluid and/or fetal heart rate abnormality, a 5-minute Apgar score r5, cord arterial pHr7.00 or the presence of the resuscitation team in the delivery room (Table 2) . However, the time for the resuscitation team to arrive in the delivery room was significantly delayed for those infants who subsequently required iNO versus those who did not, that is, 5.50±2.99 versus 3.30±0.57 minutes ( p ¼ 0.009). Similarly, there were no differences when the group was evaluated in terms of the need for HFOV. In addition, there was no difference in the arrival time of the resuscitation team to the delivery room (5.75±1.10 versus 4.33±1.22 minutes).
Relationship Between Chorioamnionitis and Severity of PPHN Histologic chorioamnionitis was noted in 10 (35%), funisitis in 12 (41%) and either one or both of these in 16 (55%) of the 29 placentas. The relationship between the presence of chorioamnionitis and/or funisitis (n ¼ 16) versus neither condition (n ¼ 13) and the need for iNO, HFOV and ECMO is shown in Table 3 . The presence of either or both abnormalities versus neither one was more likely to be associated with the need for iNO, that is, 11/16 (78%) versus 3/13 (22%) ( p ¼ 0.02, odds ratio ¼ 7.3, 95% CI 1.3, 38.8) and HFOV 7/16 (44%) versus 0 ( p ¼ 0.008, odds ratio ¼ 11, 95% CI 1.2, 109).
DISCUSSION
The data in this report describe for the first time a significant association between the presence of histologic chorioamnionitis and/or funisitis and the severity of PPHN as evidenced by the need for advanced interventions such as iNO and HFV to treat the condition. Thus, infants with histologic chorioamnionitis and/or funisitis were seven-fold more likely to be administered inhaled nitric oxide and 11-fold more likely to be treated with HFV. In addition, such infants were more likely to develop pneumothorax.
PPHN is a heterogeneous disorder characterized by extrapulmonary shunting across the fetal circuits with resultant hypoxemia. The condition reflects failure of the pulmonary vasculature to relax following birth, resulting in elevated pulmonary artery pressure. Pulmonary vascular tone is extremely sensitive to oxygen delivery with hypoxia resulting in vasoconstriction. Although many factors are involved in modulating the vasomotor tone, NO appears to play a critical role in pulmonary vasodilation. 7 NO requires the presence of the eNOS for its production. The importance of an adequate oxygen milieu to the production of NO has been repeatedly demonstrated. 1, 19, [20] [21] [22] Conversely, there are experimental data demonstrating downregulation of the eNOS and as a consequence NO production with hypoxia. 19, 23 The concurrent presence of lipopolysaccharide and proinflammatory cytokines such as IL-6 during hypoxia downregulate the production and function of eNOS still further. 11 Moreover, recent data indicate a critical role for CRP in the regulation and/or function of NO. 9, 10 Thus, elevated CRP levels have been shown to affect both the production and function of NO.
Numerous studies have demonstrated elevated proinflammatory mediators in the amniotic fluid and serum of infants born to mothers with clinical and/or histologic chorioamnionitis and/or In this report, putative markers commonly associated with PPHN, that is, meconium-stained amniotic fluid±fetal heart rate abnormalities were not related to the need for iNO and/or HFV. Interestingly, clinical chorioamnionitis was noted only in 7% of the cases, whereas histologic evidence of infection/inflammation was present in more than 50% of the study population. The inability to prospectively identify infants with high risk for severe PPHN is reflected in the observation that a single pediatric provider only was present at the delivery of approximately two-thirds of the study population. Moreover, there was a significant delay in the arrival of the resuscitation team to the delivery room of those infants who subsequently required iNO. The retrospective nature of this report does not provide an obvious explanation for this interesting observation but we speculate that the arrival of the resuscitation team in a timely manner may facilitate correction of those factors, that is, hypoxia and hypercarbia that may contribute to sustained pulmonary artery hypertension.
The association of histologic infection/inflammation with more severe PPHN also extended to the development of pneumothorax. Thus, infants with infection/inflammation were five-fold more likely to develop air leaks. The etiology for the air leaks is unclear, but may relate to higher support for these infants and/or inherent pulmonary parenchymal changes associated with infection/ inflammation.
In conclusion, the presence of histologic chorioamnionitis and/ or funisitis was associated with more severe PPHN as indicated by the use of iNO and HFV. However, this retrospective study has several limitations. First, the number of neonates enrolled in this study was small, and second, there were no proinflammatory cytokine measurements performed. Moreover, a normal control population was not included in this study because, in our institution, there was no placental pathology available from normal neonates. However, this study should serve as a substrate for future studies that examine the relationship of placental infection/inflammation, proinflammatory cytokines and PPHN. Clearly, if such an association is noted, it may open avenues for targeted strategies to treat term infants with PPHN.
